Stephen is: a member of the International Advisory
Board of the Alliance for Safe Biologic Medicines (ASBM), headquartered in
Virginia, USA; a Special Board Representative of the Consumer Health Forum of
Australia (CHF); and a biosimilars spokesperson for the International Alliance
of Patients’ Organizations (IAPO), headquartered in London.
Stephen has a
special interest in biosimilars from the patient perspective and has been
working with ASBM, CHF, IAPO and others over the past seven years in developing
and disseminating biosimilars information and educational resources to patient,
prescriber and dispenser organisations around the world.
In 2017, he was
invited to Australia on behalf of ASBM to facilitate several top-level meetings
with peak professional organisations and government bodies on the outcomes of
the ASBM Australian Prescribers Survey. Stephen has also spoken at peak body
meetings on biosimilars in The Philippines, Hong Kong, Switzerland, USA and the